CLINICAL_TRIALS
trial_result
· 2014-06-02
Clinical Trial Update: A Trial of Degarelix in Patients With Prostate Cancer [Phase 3]
Summary
Phase 3 clinical trial evaluating degarelix in prostate cancer has completed. Results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-06-02